Haijun Du
Impact in
-
- Viral-associated cancers and disorders
-
- Cancer-related molecular mechanisms research
Papers in
-
- RNA Research and Splicing 2
-
- COVID-19 Clinical Research Studies 3
- SARS-CoV-2 and COVID-19 Research 2
- Co-authors
- Yi Zeng (3 shared papers)Jun Han (10 shared papers)Shuying Li (1 shared paper)Zhan Wang (1 shared paper)Xiaoyu Zhao (1 shared paper)Jiazhang Wei (1 shared paper)Yi Zeng (1 shared paper)Ying Qin (1 shared paper)
- Journals
- Science China Life Sciences (3 papers)Frontiers in Public Health (2 papers)Oncology Reports (2 papers)Toxicology Letters (1 paper)Journal of Intensive Care Medicine (1 paper)
- Partner nations
- ChinaTaiwanUnited States
In The Last Decade
Haijun Du
28 papers receiving 191 citations
Peers
Comparison fields: 5 of 51
- Oncology 81
- Cancer Research 29
- Immunology 40
- Epidemiology 47
- Infectious Diseases 24
Countries citing papers authored by Haijun Du
This map shows the geographic impact of Haijun Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haijun Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haijun Du more than expected).
Fields of papers citing papers by Haijun Du
This network shows the impact of papers produced by Haijun Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haijun Du. The network helps show where Haijun Du may publish in the future.
Co-authors
The 25 scholars most cited alongside Haijun Du, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 41 | |
| 2 | 2010 | 32 | |
| 3 | 2011 | 16 | |
| 4 | 2012 | 14 | |
| 5 | 2021 | 13 | |
| 6 | 2018 | 11 | |
| 7 | 2023 | 9 | |
| 8 | 2025 | 9 | |
| 9 | 2022 | 8 | |
| 10 | 2023 | 5 | |
| 11 | 2015 | 5 | |
| 12 | 2021 | 4 | |
| 13 | 2013 | 4 | |
| 14 | [A serological survey of Epstein-Barr virus infection in children in Beijing]. | 2008 | 4 |
| 15 | 2023 | 3 | |
| 16 | [Effect of Nocardia rubra cell wall skeleton on the growth of HeLa cell line infected with HPV]. | 2007 | 3 |
| 17 | 2016 | 3 | |
| 18 | 2024 | 3 | |
| 19 | [Expression of peroxiredoxin III in cervical lesions]. | 2009 | 3 |
| 20 | 2021 | 2 |
About Haijun Du
Haijun Du is a scholar working on Molecular Biology, Infectious Diseases, Epidemiology, Oncology and Surgery, having authored 33 papers that have together received 204 indexed citations. Recurring topics across this work include Viral-associated cancers and disorders (6 papers), Respiratory viral infections research (3 papers), Viral Infections and Immunology Research (3 papers), COVID-19 Clinical Research Studies (3 papers), Herpesvirus Infections and Treatments (2 papers), SARS-CoV-2 and COVID-19 Research (2 papers), RNA Research and Splicing (2 papers) and Cytomegalovirus and herpesvirus research (2 papers). The work is most often cited by research in Oncology (81 citations), Cancer Research (29 citations), Immunology (40 citations), Epidemiology (47 citations) and Infectious Diseases (24 citations). Haijun Du has collaborated with scholars based in China, Taiwan and United States. Frequent co-authors include Yi Zeng, Jun Han, Shuying Li, Zhan Wang, Xiaoyu Zhao, Jiazhang Wei, Yi Zeng, Ying Qin, Yang Yong and Xiaoyi Chen. Their work appears in journals such as Science China Life Sciences, Frontiers in Public Health, Oncology Reports, Toxicology Letters and Journal of Intensive Care Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.